We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Denies Lilly, Takeda’s Request to Toss $9 Billion Damage Award Over Actos Bladder Cancer Case
Court Denies Lilly, Takeda’s Request to Toss $9 Billion Damage Award Over Actos Bladder Cancer Case
Eli Lilly and Takeda Pharmaceuticals have lost their appeal to reverse a combined jury award of $9 billion in punitive damages for hiding bladder cancer risks associated with their diabetes drug Actos, but experts say that verdict will likely be reduced.